Chairperson: J. Powell (London, GB)
| (L61) | MMP in aneurysm development. |
| A. Daugherty (Lexington KY, US) | |
| (O62) | Furin-like proprotein convertases regulate membrane type-1 matrix metalloproteinase in atherosclerosis. |
| Ph. Stawowy, H. Meyborg, D. Stibenz, J. Veinot, M. Chrétien, K. Graf, E. Fleck (Berlin, DE; Ottawa, CA) | |
| (O63) | Non-viral, electroporation mediated gene transfer of TIMP-1.ATF, a cell-surface directed MMP inhibitor, suppresses intimal hyperplasia in vein grafts more efficiently than TIMP-1 in vivo. |
| D. Eefting, M. De Vries, J. Grimbergen, H. Van Bockel, P. Quax (Leiden, NL) | |
| (O64) | EMMPRIN regulates MMP activity in cardiovascular cells. Implications in Acute Myocardial Infarction. |
| R. Schmidt, A. Bültmann, M. Ungerer, S. Fischel, N. Joghetaei, O. Bülbül, B.P. Toole, S. Thieme, A.E. May (München, Martinsried and Tübingen, DE; Charleston, US) | |
| (O65) | NF-kB promotes monocyte adhesion in vessels exposed to high intraluminal pressure. |
| S. Riou, B. Esposito, D. Stengel, E. Ninio, A. Tedgui, S. Lehoux (Paris, FR) |